Strides Pharma Science said the USFDA completed a routine cGMP inspection at its flagship Bengaluru facility from May 12 to ...

The equity shares of OneSource Specialty Pharma will commence trading on the NSE and BSE from Friday, January 24, 2025. Strides Pharma Science shares surged nearly 10 percent in early trade on January ...

Strides Pharma - Read all the latest news headline updates on Strides Pharma. Get all the Strides Pharma breaking news updates, videos, photostories and more at Business Standard.

Strides Pharma reports a 51% Q4 profit increase to ₹129 crore, driven by growth in key markets excluding the US.

Strides Pharma Science Ltd (BOM:532531) reported a significant improvement in gross margins, reaching 60% in the quarter. The company achieved a 12% year-on-year increase in EBITDA, marking its ...

Strides Pharma Science has informed the stock exchanges that the United States Food and Drug Administration (USFDA) has ...

US markets lifted Strides Pharma Science's Q4 profit, even as its US business remained largely flat amid a weak flu season ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

The average one-year price target for Strides Pharma Science (NSEI:STAR) has been revised to ₹ 1,244.40 / share. This is a decrease of 19.21% from the prior estimate of ₹ 1,540.20 dated September 27, ...

The average one-year price target for Strides Pharma Science (NSE:STAR) has been revised to 565.76 / share. This is an increase of 13.66% from the prior estimate of 497.76 dated August 31, 2023. The ...